A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers
Clinical trial NCT04350463 · COMPLETED
Trial details
- NCT number
- NCT04350463
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2023-12-19
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.